Semaglutide Injection Pen

Overview

The Semaglutide Injection Pen is a pre-filled, multi-dose injection pen device containing Semaglutide, a long-acting GLP-1 receptor agonist. This pen delivery system offers research-grade convenience with precise dosing capabilities, eliminating the need for reconstitution and providing consistent delivery for research protocols.

The pen format is particularly well-suited for Semaglutide research due to the peptide's weekly dosing profile, allowing multiple administrations from a single pen device with maintained potency and stability throughout the use period.

For detailed compound information, mechanism of action, and research applications, please refer to the Semaglutide lyophilized powder product page.

Chemical Profile

Mechanism of Action

Semaglutide activates GLP-1 receptors, promoting glucose-dependent insulin secretion, appetite suppression, and delayed gastric emptying. Its C-18 fatty diacid modification enables albumin binding for an extended ~7-day half-life.

The pen delivery format provides consistent subcutaneous absorption, producing reproducible pharmacokinetic profiles suitable for standardized weekly research dosing protocols.

For comprehensive mechanism details, see the Semaglutide lyophilized powder product page.

Research Applications

• GLP-1R agonist pen delivery research
• Weekly dosing protocol optimization
• Metabolic research with standardized delivery
• Comparative delivery format studies

Handling & Reconstitution

1. 1Remove the pen from refrigerated storage and allow it to reach room temperature (15-25 minutes).
2. 2Attach a new sterile pen needle according to device instructions.
3. 3Prime the pen by dialing and expelling a small test dose.
4. 4Dial the desired research dose.
5. 5Administer subcutaneously per research protocol.
6. 6Remove and safely dispose of the needle after each use.
7. 7Return the pen to refrigerated storage (2°C – 8°C) immediately after use.